About
PlaqueTec develops technology to profile the biological mechanisms of coronary artery disease, enabling the identification of new drug targets and supporting precision medicine approaches for patients with atherosclerosis.
Explore PlaqueTec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.